Regenerative medicine company AVITA Medical (ASX:AVH) has announced that the US FDA has approved its premarket approval supplement for the use of the RECELL System to treat full-thickness skin defects. …
AVITA Medical announces US approval of RECELL for full thickness skin defects
June 8, 2023 Australian Biotech
Latest Video
New Stories
-
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News -
Australia's 2026 flu vaccination season barely moves the needle on uptake
September 15, 2026 - - Latest News -
Persistent fatigue could be an overlooked sign of liver disease
September 15, 2026 - - Latest News -
Noxopharm moves lupus skin therapy toward next human trial
September 14, 2026 - - Australian Biotech -
Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends
September 14, 2026 - - Latest News -
Diabetes and cancer blood tests reach WA and NT patients under new Healius deal
September 14, 2026 - - Australian Biotech -
FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug
September 14, 2026 - - Australian Biotech